Swine Flu: se notes for links . - April 24, 2009, 11:19 PM

don't comment until you check the dates all videos are accurate at the time of posting. responses with updated info:' http://www.youtube.com/watch?v=C8yY23d4Rxs http://www.youtube.com/watch?v=6rGj4A-3_1Q don't comment until you check the dates all videos are accurate at the time of posting. *****I'm deleting all NWO and conspiracy crap, and dealing with the topic on hand . you mention chem trails, Bilderberg or any conspiracy theory your comment gets deleted . **** 80 dead in Mexico over 600 confirmed cases U.S. Human Cases of Swine Flu Infection State # of laboratory confirmed cases California 7 cases Kansas 2 cases New York City 8 cases Ohio 1 case Texas 2 cases TOTAL COUNT 20 cases 26 possible exposures in Australia face mask article: http://www.cdc.gov/swineflu/masks.htm Information on the effectiveness of facemasks1 and respirators2 for the control of influenza in community settings is extremely limited. Thus, it is difficult to assess their potential effectiveness in controlling swine influenza A (H1N1) virus transmission in these settings. In the absence of clear scientific data, the interim recommendations below have been developed on the basis of public health judgment and the historical use of facemasks and respirators in other settings. http://www.cdc.gov/swineflu/recommendations.htm Infectious period The infectious period for a confirmed case of swine influenza A (H1N1) virus infection is defined as 1 day prior to the cases illness onset to 7 days after onset. A suspected case of swine influenza A (H1N1) virus infection is defined as: 1) A person with acute respiratory illness who was a close contact to a confirmed case of swine influenza A (H1N1) virus infection during the cases infectious period, OR 2) A person with an acute respiratory illness who traveled to or resides in an area where there are confirmed cases of swine influenza A (H1N1) virus infection. Close contact is defined as: within about 6 feet of an ill person who is a confirmed or suspected case of swine influenza A (H1N1) virus infection during the cases infectious period. Acute respiratory illness is defined as: recent onset of at least two of the following: rhinorrhea or nasal congestion, sore throat, cough (with or without fever or feverishness) High-risk group for complications of influenza is defined as: a person who is at high-risk for complications of seasonal influenza: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr57e717a1.htm. However, it too early to ascertain what persons are at high-risk for complications of swine influenza A (H1N1) virus infection. This guidance will be updated as new information is available. Clinicians should consider swine influenza A (H1N1) virus infection in the differential diagnosis of patients with febrile respiratory disease and who 1) live in areas in the U.S. with confirmed human cases of swine influenza A (H1N1) virus infection or 2) who traveled recently to Mexico or were in contact with persons who had febrile respiratory illness and were in the areas of the U.S. with confirmed swine influenza cases or Mexico in the 7 days preceding their illness onset. Special Considerations for Children Aspirin or aspirin-containing products (e.g. bismuth subsalicylate Pepto Bismol) should not be administered to any confirmed or suspected ill case of swine influenza A (H1N1) virus infection aged 18 years old and younger due to the risk of Reye syndrome. For relief of fever, other anti-pyretic medications are recommended such as acetaminophen or non steroidal anti-inflammatory drugs. Antiviral Resistance This swine influenza A (H1N1) virus is sensitive (susceptible) to the neuraminidase inhibitor antiviral medications zanamivir and oseltamivir. It is resistant to the adamantane antiviral medications amantadine and rimantadine. Seasonal influenza A and B viruses continue to circulate at low levels in the U.S. and in Mexico. Currently circulating human influenza A (H1N1) viruses are resistant to oseltamivir and sensitive (susceptible) to zanamivir, amantadine and rimantadine. Currently circulating human influenza A (H3N2) viruses are resistant to amantadine and rimantadine, but sensitive (susceptible) to oseltamivir and zanamivir. Therefore, at this time antiviral treatment recommendations for suspected cases of swine influenza A (H1N1) virus infection need to consider potential infection with swine influenza A (H1N1) virus as well as human influenza viruses, and their different antiviral susceptibilities.